A Day Up For TScan Therapeutics Inc.
TScan Therapeutics Inc. (TCRX:NASDAQ) jumped higher at $3.4, a gain of 58.1%. On Tue, May 09, 2023, TCRX:NASDAQ hit a New 2-Week High of $3.4. The stock got featured on our News Catalysts scanner on Tue, May 09, 2023 at 11:23 AM in the 'PATNERSHIP' category. From Wed, Apr 26, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Tue, May 09, 2023 at $6.03 with a volume of 49M+.
About TScan Therapeutics Inc. (TCRX:NASDAQ)
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer.
Top 10 Gainers:
- Shengfeng Development Limited (SFWL:NASDAQ), 98.65%
- ClearOne, Inc. (CLRO:NASDAQ), 72.58%
- TScan Therapeutics Inc. (TCRX:NASDAQ), 58.14%
- Bright Health Group Inc. (BHG:NYSE), 52.94%
- Y-mAbs Therapeutics, Inc. (YMAB:NASDAQ), 36.34%
- Venus Concept Inc. (VERO:NASDAQ), 34.89%
- Uxin Limited (UXIN:NASDAQ), 32.79%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 29.48%
- Latham Group Inc. (SWIM:NASDAQ), 29.3%
- MultiPlan Corporation Class A (MPLN:NYSE), 29.07%